nect Biopharma (CNTB)
Search documents
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
Newsfilter· 2024-03-19 12:30
SAN DIEGO and TAICANG, China, March 19, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today announced that Zheng Wei, Ph.D., Co-Founder and CEO, and Raúl Collazo, Ph.D., Global Head of Medical Affairs will participate in H.C. Wainwright 2nd ...
nect Biopharma (CNTB) - 2022 Q4 - Annual Report
2023-04-10 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of ...
nect Biopharma (CNTB) - 2022 Q4 - Annual Report
2023-04-10 16:00
Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business Update CDE's Pre-NDA Feedback Confirms CBP-201 for Atopic Dermatitis on Track for NDA Submission in China by End of First Quarter 2024 SAN DIEGO and TAICANG, SUZHOU, China – April 11, 2023 – Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced financial results for ...
nect Biopharma (CNTB) - 2022 Q2 - Earnings Call Transcript
2022-09-14 00:51
Connect Biopharma Holdings Limited (NASDAQ:CNTB) Q2 2022 Results Conference Call September 13, 2022 4:30 PM ET Company Participants Ina McGuinness - IR Dr. Zheng Wei - Co-Founder and CEO Dr. Chin Lee - Chief Medical Officer Steven Chan - CFO Conference Call Participants Louise Chen - Cantor Fitzgerald Thomas Smith - SVB Securities Kelly Shi - Jefferies Joe Catanzaro - Piper Sandler Operator Good day and thank you for standing by. Welcome to Connect Biopharma First Half 2022 Financial Results Conference Call ...